AIM ImmunoTech (AMEX:AIM) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.18) by 138.89 percent. This is a 88.32 percent increase over losses of $(3.68) per share from the same period last year. The company reported $26.000 thousand in sales this quarter. This is a 4.00 percent increase over sales of $25.000 thousand the same period last year.